Strides Arcolab, U.S. firm ink 5-yr deal

By agencies   |   Wednesday, 30 March 2005, 08:00 Hrs
Printer Print Email Email
BANGALORE:Strides Arcolab Ltd has struck a five-year contract with a U.S.based firm to develop four injectable products for the United States market in a deal valued at $ 90-160 million.

The Bangalore based pharma company will develop, license and manufacture the products that will be available in the U.S. market from the financial year 2007 onwards.

Strides has been following a strategy of partnerships with foreign pharmaceutical and healthcare companies. Earlier this year, it enhanced a partnership with Australia's Mayne

The chief executive officer for the Indian operations of Strides, K R Ravishankar, said the deal would require additional manufacturing capacity, for which the company was already in the process of raising funds through foreign currency convertible bonds (FCCBs).

GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..